Charles, named after the trolley-tracked avenue near Bazan's home, is in early-stage clinical trials with its new drug, SCP-1.

FORBES: Health

Its founder, Nicolas Bazan, a 60-year-old neuroscientist, has a seemingly simple and elegant answer to the pain problem: chemically combine a derivative of acetaminophen with a saccharinelike component.

FORBES: Magazine Article

"There's nothing out there that is as effective, that is nonnarcotic and is at least as powerful as acetaminophen, " Bazan claims, adding that unlike acetaminophen, his drug will not lower fever.

FORBES: Magazine Article